Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.QAI.0000018000.56638.4PMID 12131564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing

  2001cited by this paper
• Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

  2001cited by this paper
• Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study

  2000cited by this paper
• Resistance, fitness, adherence, and potency: mapping the paths to virologic failure.

  2000cited by this paper
• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

  2000cited by this paper
• Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

  2000cited by this paper
• Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.

  2000cited by this paper
• Patient‐Reported Nonadherence to HAART Is Related to Protease Inhibitor Levels

  2000cited by this paper
• Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

  2000cited by this paper
• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

  2000cited by this paper
• Measuring Adherence to Antiretroviral Medications in Clinical Trials

  2000cited by this paper
• Nelfinavir: an update on its use in HIV infection.

  2000cited by this paper
• Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

  1999cited by this paper
• Indinavir Concentrations and Antiviral Effect

  1999cited by this paper
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.

  1999cited by this paper
• Incidence and Predictors of Virologic Failure of Antiretroviral Triple-Drug Therapy in a Community-Based Cohort

  1999cited by this paper
• Indinavir: a review of its use in the management of HIV infection.

  1999cited by this paper
• Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

  1999cited by this paper
• The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.

  1999cited by this paper
• Public health implications of antiretroviral therapy and HIV drug resistance.

  1998cited by this paper
• Characterizing patterns of drug‐taking behavior with a multiple drug regimen in an AIDS clinical trial

  1998cited by this paper
• Drug-resistant HIV-1: the virus strikes back.

  1998cited by this paper
• The effect of plasma drug concentrations on HIV‐1 clearance rate during quadruple drug therapy

  1998cited by this paper
• Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple Therapy

  1998cited by this paper
• Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

  1998cited by this paper
• A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

  1998cited by this paper
• Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study

  1997cited by this paper
• Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

  1996cited by this paper
• Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

  1996cited by this paper
• Patient compliance and drug failure in protease inhibitor monotherapy.

  1996cited by this paper
• Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

  1996cited by this paper
• Patient compliance and medical research

  1994cited by this paper
• On white-coat effects and the electronic monitoring of compliance.

  1990cited by this paper
• How often is medication taken as prescribed? A novel assessment technique.

  1989cited by this paper

• Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: a national study.

  2024cites this paper
• Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment

  2022cites this paper
• HIV_A_346358 33..44

  2022cites this paper
• A Comparison of Adherence and CD4 Cell Count with Respect to Virologic Failure Among HIV-Infected Adults Under Combination Antiretroviral Therapy (cART) at Felege Hiwot Teaching and Specialized Hospital, Bahir Dar, Ethiopia

  2022cites this paper
• Incidence of Mortality and Its Predictors Among HIV Positive Adults on Antiretroviral Therapy in University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

  2021cites this paper
• Avoiding Drug Resistance in HIV Reverse Transcriptase.

  2021cites this paper
• Occupational barriers to accessing and adhering to antiretroviral therapy for female sex workers living with HIV in South Africa

  2020cites this paper
• Social Determinants of HIV Treatment Engagement among Postpartum Black Women Living with HIV (WLWH)

  2019cites this paper
• HIV PATIENTS PERCEPTION OF PHARMACISTS CARING ATTITUDE AND ITS INFLUENCE ON ADHERENCE

  2019cites this paper
• HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru

  2019cites this paper
• Reliability and validity of the Chinese version of the HIV Treatment Adherence Self-Efficacy Scale in mainland China

  2017cites this paper
• Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy

  2017cites this paper
• Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low‐ and Middle‐Income Countries

  2017cites this paper
• Causes of HIV Drug Non-Adherence in Korea: Korea HIV/AIDS Cohort Study, 2006-2015

  2017cites this paper
• Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India

  2016cites this paper
• Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles

  2016cites this paper
• A Society Based Research to Assess Adherence of Antiretroviral Therapy

  2015cites this paper
• Barfod : Adherence to HIV treatment i Adherence to HIV treatment . Patient perceptions and physician communication studied by observation , interviews , questionnaires , and patients ’ files December 2004

  2015cites this paper
• Alcohol use and HIV disease management: The impact of individual and partner-level alcohol use among HIV-positive men who have sex with men

  2014cites this paper
• Association between Dog Guardianship and HIV Clinical Outcomes

  2014cites this paper
• Association between dog guardianship and HIV clinical outcomes.

  2014cites this paper
• Stimulant use and HIV disease management among men in same-sex relationships.

  2014cites this paper
• Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study

  2013cites this paper
• Associations between the legal context of HIV, perceived social capital, and HIV antiretroviral adherence in North America

  2013influential citation
• Engagement with Health Care Providers Affects Self- Efficacy, Self-Esteem, Medication Adherence and Quality of Life in People Living with HIV

  2013cites this paper
• Trends in Prevalence of HIV‐1 Drug Resistance in Thailand 2009–2010

  2013cites this paper
• Progress of mother‐to‐child transmission of HIV programs in China: successes, challenges and way forward

  2013cites this paper
• HIV drug resistance among adults and children in sub-Saharan Africa

  2013cites this paper
• Primary Relationships, HIV Treatment Adherence, and Virologic Control

  2012cites this paper
• Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus

  2012cites this paper
• Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus

  2012cites this paper
• Mechanism of HIV antiretroviral drugs progress toward drug resistance

  2012cites this paper
• Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial.

  2012cites this paper
• Advances in the Conceptualization and Measurement of Health Care Empowerment: Development and Validation of the Health Care Empowerment Inventory

  2012cites this paper
• Adherence to Antiretroviral Therapy in Currently Changed Treatment Guideline on People Living with HIV/AIDS at Bishofitu Hospital, East Shoa, 2011. Ethiopa.

  2011cites this paper
• HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.

  2011cites this paper
• Improving Coping Skills for Self-management of Treatment Side Effects Can Reduce Antiretroviral Medication Nonadherence among People Living with HIV

  2010cites this paper
• Antiretroviral medication adherence and the development of class-specific antiretroviral resistance

  2009cites this paper
• An alternative methodology for the prediction of adherence to anti HIV treatment

  2009cites this paper
• Addressing Adherence to Antiretroviral Therapy in Ouagadougou, Burkina Faso: Insights from hospital ethnography

  2009cites this paper
• Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.

  2009cites this paper
• Adherencia y aspectos psicológicos en pacientes adultos infectados por el VIH con prolongada exposición a tratamiento antirretroviral

  2009cites this paper
• Forgiveness of non-adherence to HIV-1 antiretroviral therapy.

  2008cites this paper
• Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique.

  2008cites this paper
• Immunological Rebound after Initiation of Highly Active Antiretroviral Therapy in Treatment-Naive Patients

  2008cites this paper
• Coping with HIV Treatment Side Effects: Conceptualization, Measurement, and Linkages

  2007cites this paper
• Optimal drug treatment regimens for HIV depend on adherence.

  2007cites this paper
• Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

  2007cites this paper
• The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)

  2007cites this paper
• Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338)

  2007cites this paper
• Understanding patients' adherence to antiretroviral therapy: A mixed-methods study in Arusha, Tanzania

  2007cites this paper
• Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings

  2007cites this paper
• Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness

  2006cites this paper
• Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients

  2006cites this paper
• Moving From Theory to Research to Practice: Implementing an Effective Dyadic Intervention to Improve Antiretroviral Adherence for Clinic Patients

  2006influential citation
• Longitudinal analyses of medication adherence data in hiv-infected illicit drug users

  2006cites this paper
• Current therapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome

  2006cites this paper
• Initiation of antiretroviral therapy

  2006cites this paper
• Significance of Variation Within HIV, EBV, and KSHV Subtypes

  2006cites this paper
• Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

  2005cites this paper
• Couple-focused support to improve HIV medication adherence: a randomized controlled trial

  2005cites this paper
• Improving adherence to antiretroviral therapy.

  2005cites this paper
• HIV-1 Drug Resistance Evolution Among Patients on Potent Combination Antiretroviral Therapy With Detectable Viremia

  2005cites this paper
• British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005)

  2005cites this paper
• Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir.

  2005cites this paper
• Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven.

  2005cites this paper
• La prise en charge en médecine générale du patient atteint par le VIH Global HIV care in general/family practice

  2005cites this paper
• Risk factors for suboptimal adherence and facilitators of adherence to HAART in HIV-infection

  2005cites this paper
• Four Measures of Antiretroviral Medication Adherence and Virologic Response in AIDS Clinical Trials Group Study 359

  2005cites this paper
• Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates.

  2004cites this paper
• Diversity of Human Immunodeficiency Virus Type 1 Subtype A and CRF03_AB Protease in Eastern Europe: Selection of the V77I Variant and Its Rapid Spread in Injecting Drug User Populations

  2004cites this paper
• Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south

  2004cites this paper
• Paradoxes of adherence and drug resistance to HIV antiretroviral therapy.

  2004cites this paper
• Adherence to antiretroviral therapy: An update of current concepts

  2004cites this paper
• There are no paradoxes of adherence and drug resistance to HIV antiretroviral therapy.

  2004cites this paper
• Measuring Adherence to Antiretroviral Therapy in a Diverse Population Using a Visual Analogue Scale

  2004cites this paper
• Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine.

  2004cites this paper
• Virologic and immunologic response to highly active antiretroviral therapy

  2004cites this paper
• Mutations associated with hypersusceptibility...and with good adherence.

  2004cites this paper
• Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin.

  2004cites this paper
• Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.

  2004cites this paper
• Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing

  2004cites this paper
• Human Immunodeficiency Virus Type 1 Infection in Oman: Antiretroviral Therapy and Frequencies of Drug Resistance Mutations

  2004cites this paper
• Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study

  2004cites this paper
• Update on the virologic and immunologic response to highly active antiretroviral therapy

  2004cites this paper
• Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study

  2004cites this paper
• Adherence to antiretroviral therapies: state of the science.

  2004cites this paper
• High levels of adherence do not prevent accumulation of HIV drug resistance mutations

  2003cites this paper
• Doubts about DOT: antiretroviral therapy for resource‐poor countries

  2003cites this paper
• Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.

  2003cites this paper
• Patterns of adherence to antiretroviral medications: the value of electronic monitoring

  2003cites this paper
• Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.

  2003cites this paper
• The promise and peril of HIV treatment.

  2002cites this paper
• Is average adherence to HIV antiretroviral therapy enough?

  2002cites this paper
• Impact of Genotypic Resistance Testing on Selection of Salvage Regimen in Clinical Practice

  2002cites this paper